Stablevax reported it comprises approved vaccines which are dried from a solution of stabilizing sugar into a special sponge stored in a normal syringe. They are pre-dosed and safe, to use you just add water. Stable vaccines will be manufactured at c. the same price as current products.
“Vaccines are perishable, requiring constant & precise refrigeration from the manufacturer to the patient, be it in a UK Hospital or a clinic in Africa. The WHO estimates that c 50% of all vaccines are wasted in spite of c $400m p.a. spent on the global Cold Chain.”
The company noted that the solution will allow vaccines to be transported and stored for years without refrigeration whilst complying with the protocols set by the WHO. It’s an important breakthrough that can save many lives.
“The current project plan involves the Tetanus vaccine processed through Clinical Trials in Humans, this achievement will significantly enhance the value of the invention and allow us to set up pilot scale production as the last step to commercialisation to enter the c. $36 bn human vaccine market and exploit this truly disruptive invention.”
Originally seeking £750,000, the company is planning to use the funds from the Crowdcube round to continue the growth and development of its plans. Stablepharma is offering 10.73% in equity at a £10 million pre-money valuation. The funding round is set to close on Wednesday.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!